NAGA CHANDRIKA PALLAM, M.PHARM
ASSIST.PROFESSOR
Geethanjali College of Pharmacy, Hyd.
1
DRUG REGULATORY AFFAIRS
INDUSTRIAL PHARMACY- II
B.PHARM IV YEARS IST SEM
LEARNING OBJECTIVES
 To gain the essential knowledge and skills required to help
companies to work in regulatory environment.
 Acquire the foundation to work within or in variety of areas including
medical products development, pharmaceutical formulations, sales,
strategic marketing and clinical investigations.
 To know about regulatory process in drug development,
formulations, API.
 To sharpen the understanding of laws that governs the development
manufacturing, and commercializing along with the distribution of
drugs, biologics and medical devices.
2
Regulatory affair is a profession which acts as the interface between
pharmaceutical industries and Drug Regulatory Authorities
(Government authorities) around the world.
3
PHARMACEUTICAL
INDUSTRIES DRUG REGULATORY AUTHORITIES
Goal of regulatory affairs professional is protection of human
health, ensuring safety, efficacy, and quality of drugs,
ensuring accuracy of product information.
4
NEED?
The need of regulatory affairs of pharmaceutical
was felt back in 1950 due to multiple tragedies i.e.
sulfanilamide elixir, vaccine tragedy and thalidomide
tragedy etc
5
Harold Cole warkins
Seventy one adults and 34 children died in the fall of 1937
after taking a drug called Elixir sulfanilamide to treat a
variety of ailments, from gonorrhea to sore throat.
At that time, no formal government approval required to
market new drugs.
The disaster provoked a public out cry that led to the
passage of the 1938 food drug and cosmetics acts, which
gave FDA power to monitor the safety of new drugs
6
7
8
ROLE OF DRA
What DRA actually do
MAJOR REGULATORY AUTHORITIES
INDIA- Central Drug Standard Control Organization. Drug
controller general of India
US--- Food and Drug Administration USFDA.
UK ---- Medicines and Health care products regulatory
Agency (MHRA)
AUSTRALIA ---Therapeutic Goods Administration (TGA)
JAPAN---- Japanese Ministry of health, Labor and welfare
(MHLW)
EUROPE--- European Directorate for quality of Medicines
(EDQM), European Medicines Evaluations
9
Why Drug regulatory affairs?
10
Drug development and in order to develop the most
efficient and safe pharmaceutical products.
The path of the drug registration is laid down with good
intended but can be complicated.
Somebody who gather all relevant information in one
umbrella to bring product in the market for sell.
Helps to reduce number of development failures
On what issue DRA department provide
assistance
 Licensing
 Registration
 Development
 Manufacturing
 Quality guidance
 Pricing
 Marketing
 GMP
 GLP
 GCP
 Patent
 Copyright
 Trademark
 Pharma-covigilance
11
THANK YOU
12

Regulatory affairs

  • 1.
    NAGA CHANDRIKA PALLAM,M.PHARM ASSIST.PROFESSOR Geethanjali College of Pharmacy, Hyd. 1 DRUG REGULATORY AFFAIRS INDUSTRIAL PHARMACY- II B.PHARM IV YEARS IST SEM
  • 2.
    LEARNING OBJECTIVES  Togain the essential knowledge and skills required to help companies to work in regulatory environment.  Acquire the foundation to work within or in variety of areas including medical products development, pharmaceutical formulations, sales, strategic marketing and clinical investigations.  To know about regulatory process in drug development, formulations, API.  To sharpen the understanding of laws that governs the development manufacturing, and commercializing along with the distribution of drugs, biologics and medical devices. 2
  • 3.
    Regulatory affair isa profession which acts as the interface between pharmaceutical industries and Drug Regulatory Authorities (Government authorities) around the world. 3 PHARMACEUTICAL INDUSTRIES DRUG REGULATORY AUTHORITIES
  • 4.
    Goal of regulatoryaffairs professional is protection of human health, ensuring safety, efficacy, and quality of drugs, ensuring accuracy of product information. 4
  • 5.
    NEED? The need ofregulatory affairs of pharmaceutical was felt back in 1950 due to multiple tragedies i.e. sulfanilamide elixir, vaccine tragedy and thalidomide tragedy etc 5 Harold Cole warkins
  • 6.
    Seventy one adultsand 34 children died in the fall of 1937 after taking a drug called Elixir sulfanilamide to treat a variety of ailments, from gonorrhea to sore throat. At that time, no formal government approval required to market new drugs. The disaster provoked a public out cry that led to the passage of the 1938 food drug and cosmetics acts, which gave FDA power to monitor the safety of new drugs 6
  • 7.
  • 8.
    8 ROLE OF DRA WhatDRA actually do
  • 9.
    MAJOR REGULATORY AUTHORITIES INDIA-Central Drug Standard Control Organization. Drug controller general of India US--- Food and Drug Administration USFDA. UK ---- Medicines and Health care products regulatory Agency (MHRA) AUSTRALIA ---Therapeutic Goods Administration (TGA) JAPAN---- Japanese Ministry of health, Labor and welfare (MHLW) EUROPE--- European Directorate for quality of Medicines (EDQM), European Medicines Evaluations 9
  • 10.
    Why Drug regulatoryaffairs? 10 Drug development and in order to develop the most efficient and safe pharmaceutical products. The path of the drug registration is laid down with good intended but can be complicated. Somebody who gather all relevant information in one umbrella to bring product in the market for sell. Helps to reduce number of development failures
  • 11.
    On what issueDRA department provide assistance  Licensing  Registration  Development  Manufacturing  Quality guidance  Pricing  Marketing  GMP  GLP  GCP  Patent  Copyright  Trademark  Pharma-covigilance 11
  • 12.